Glycaemic control in the perioperative period

British Journal of Anaesthesia

Volumn 111, Issue SUPPL.1, 2013, Pages

  Sebranek, J J ^a   Lugli, A Kopp ^b   Coursin, D B ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

blood; diabetes; glucose; intensive care; postoperative; preoperative; surgery

Indexed keywords

ACARBOSE; ALPHA GLUCOSIDASE INHIBITOR; BIGUANIDE DERIVATIVE; CHLORPROPAMIDE; EXENDIN 4; GLIBENCLAMIDE; GLIMEPIRIDE; GLIPIZIDE; GLITAZONE DERIVATIVE; GLUCOSE; HEMOGLOBIN; HEMOGLOBIN A1C; INSULIN; INSULIN ASPART; INSULIN LISPRO; ISOPHANE INSULIN; LIRAGLUTIDE; MEGLITINIDE; METFORMIN; MIGLITOL; NATEGLINIDE; PIOGLITAZONE; PRAMLINTIDE; RECOMBINANT HUMAN INSULIN; REPAGLINIDE; ROSIGLITAZONE; SAXAGLIPTIN; SITAGLIPTIN; SULFONYLUREA DERIVATIVE; TOLBUTAMIDE; UNINDEXED DRUG;

ACUTE PANCREATITIS; ARTICLE; ARTIFICIAL VENTILATION; BLOOD GLUCOSE MONITORING; CAROTID ENDARTERECTOMY; CEREBROVASCULAR ACCIDENT; COLORECTAL SURGERY; CONGESTIVE HEART FAILURE; CORONARY ARTERY BYPASS GRAFT; CRITICALLY ILL PATIENT; DIABETES MELLITUS; DIARRHEA; DRUG DOSE TITRATION; DRUG HALF LIFE; DRUG MECHANISM; FLATULENCE; FLUID RETENTION; GASTROINTESTINAL IRRITATION; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLYCEMIC CONTROL; HEART DISEASE; HEART INFARCTION; HEART SURGERY; HIGH RISK PATIENT; HUMAN; HYPOGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; INSULIN SENSITIVITY; INSULIN TREATMENT; INTENSIVE CARE; KIDNEY DISEASE; LABORATORY TEST; LACTIC ACIDOSIS; LENGTH OF STAY; LIVER TOXICITY; LUNG DISEASE; LUNG EMBOLISM; MEASUREMENT ACCURACY; MEASUREMENT ERROR; MEDICAL HISTORY; MEDICATION ERROR; META ANALYSIS (TOPIC); MORBIDITY; MORNING DOSAGE; NAUSEA; NEUROLOGIC DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; NUTRITIONAL SUPPORT; ORAL GLUCOSE TOLERANCE TEST; OUTPATIENT CARE; PATIENT EDUCATION; PERIOPERATIVE PERIOD; PLEURA EFFUSION; POINT OF CARE TESTING; POSTOPERATIVE COMPLICATION; POSTOPERATIVE ILEUS; POSTOPERATIVE INFECTION; POSTOPERATIVE NAUSEA AND VOMITING; PRACTICE GUIDELINE; PREGNANCY DIABETES MELLITUS; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REPEATED DRUG DOSE; RESUSCITATION; SEPSIS; SIDE EFFECT; SURGICAL INFECTION; SURGICAL MORTALITY; SURGICAL RISK; THYROID MEDULLARY CARCINOMA; TOTAL HIP PROSTHESIS; TOTAL KNEE REPLACEMENT; TRANSIENT ISCHEMIC ATTACK; URINARY TRACT INFECTION; VOMITING; WARD; WEIGHT REDUCTION;

EID: 84890578004     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aet381     Document Type: Article

References (141)

1. Dungan KM, Braithwaite SS, Preiser JC. Stress hyperglycaemia. Lancet 2009; 373: 1798-807
2. Lena D, Kalfon P, Preiser JC, Ichai C. Glycemic control in the intensive care unit and during the postoperative period. Anesthesiology 2011; 114: 438-44
3. Dhatariya K, Levy N, Kilvert A, et al. NHS diabetes guideline for the perioperative management of the adult patient with diabetes. Diabet Med 2012; 29: 420-33
4. Egi M, Bellomo R, Stachowski E, et al. Blood glucose concentration and outcome of critical illness: the impact of diabetes. Crit Care Med 2008; 36: 2249-55
5. Umpierrez GE, Isaacs SD, BazarganN, YouX, Thaler LM, Kitabchi AE. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab 2002; 87: 978-82
6. Finfer S, Liu B, Chittock DR, et al. Hypoglycemia and risk of death in critically ill patients. N Engl J Med 2012; 367: 1108-18
7. Krinsley JS, Grover A. Severe hypoglycemia in critically ill patients: risk factors and outcomes. Crit Care Med 2007; 35: 2262-7
8. World Health Organization. World Health Organization Guidelines for Safe Surgery. Geneva:World Health Organization, 2009.
9. Lipshutz AK, Gropper MA. Perioperative glycemic control: an evidence-based review. Anesthesiology 2009; 110: 408-21
10. Akhtar S, Barash PG, Inzucchi SE. Scientific principles and clinical implications of perioperative glucose regulation and control. Anesth Analg 2010; 110: 478-97
11. Fahy BG, Sheehy AM, Coursin DB. Glucose control in the intensive care unit. Crit Care Med 2009; 37: 1769-76
12. GodoyDA, Di Napoli M, BiestroA, Lenhardt R. Perioperative glucose control in neurosurgical patients. Anesthesiol Res Pract 2012; 2012: 690362
13. McDonnell ME, Alexanian SM, White L, Lazar HL. A primer for achieving glycemic control in the cardiac surgical patient. J Card Surg 2012; 27: 470-7
14. Ryan EA, SiaWW, Khurana R, Marnoch CA, Nerenberg KA, Ghosh M. Glucose control during labour in diabetic women. J Obstet Gynaecol Can 2012; 34: 1149-57
15. Sheehy AM, Benca J, Glinberg SL, et al. Preoperative 'NPO' as an opportunity for diabetes screening. J Hosp Med 2012; 7: 611-6
16. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators. Lancet 2000; 355: 253-9
17. American College of Cardiology/American Heart Association Task Force on Practice Guidelines, American Society of Echocardiography, American Society of Nuclear Cardiology. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). Anesth Analg 2008; 106: 685-712
18. Carson JL, Scholz PM, Chen AY, Peterson ED, Gold J, Schneider SH. Diabetes mellitus increases short-term mortality and morbidity in patients undergoing coronary artery bypass graft surgery. J Am Coll Cardiol 2002; 40: 418-23
19. Szabo Z, Hakanson E, Svedjeholm R. Early postoperative outcome and medium-term survival in 540 diabetic and 2239 nondiabetic patients undergoing coronary artery bypass grafting. Ann Thorac Surg 2002; 74: 712-9
20. Lazar HL, McDonnell M, Chipkin SR, et al. The Society of Thoracic Surgeons practice guideline series: blood glucose management during adult cardiac surgery. Ann Thorac Surg 2009; 87: 663-9
21. Furnary AP,Wu Y. Eliminating the diabetic disadvantage: the Portland Diabetic Project. Semin Thorac Cardiovasc Surg 2006; 18: 302-8
22. Bagry HS, Raghavendran S, Carli F. Metabolic syndromeand insulin resistance: perioperative considerations. Anesthesiology 2008; 108: 506-23
23. Hofferberth SC, Newcomb AE, Ryan MC, et al. High incidence of insulin resistance and dysglycemia amongst nondiabetic cardiac surgical patients. Ann Thorac Surg 2012; 94: 117-22
24. Milaskiewicz RM, Hall GM. Diabetes and anaesthesia: the past decade. Br J Anaesth 1992; 68: 198-206
25. Thourani VH, Weintraub WS, Stein B, et al. Influence of diabetes mellitus on early and late outcome after coronary artery bypass grafting. Ann Thorac Surg 1999; 67: 1045-52
26. Ascione R, Rogers CA, Rajakaruna C, Angelini GD. Inadequate blood glucose control is associated with in-hospital mortality and morbidity in diabetic and nondiabetic patients undergoing cardiac surgery. Circulation 2008; 118: 113-23
27. Anderson RE, Klerdal K, Ivert T, Hammar N, Barr G, Owall A. Are even impaired fasting blood glucose levels preoperatively associated with increased mortality after CABG surgery? Eur Heart J 2005; 26: 1513-8
28. Genuth S, Alberti KG, Bennett P, et al. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003; 26: 3160-7
29. American Diabetes Association. Standards of medical care in diabetes- 2013. Diabetes Care 2013; 36 (Suppl. 1): S11-66
30. Sheehy AM, Flood GE, TuanWJ, Liou JI, Coursin DB, Smith MA. Analysis of guidelines for screening diabetes mellitus inanambulatory population. Mayo Clin Proc 2010; 85: 27-35
31. Abdelmalak B,AbdelmalakJB, Knittel J, et al.Theprevalenceof undiagnosed diabetes in non-cardiac surgery patients, an observational study. Can J Anaesth 2010; 57: 1058-64
32. Lauruschkat AH, Arnrich B, Albert AA, et al. Prevalence and risks of undiagnosed diabetes mellitus in patients undergoing coronary artery bypass grafting. Circulation 2005; 112: 2397-402
33. Kohl BA, Schwartz S. How to manage perioperative endocrine insufficiency. Anesthesiol Clin 2010; 28: 139-55
34. Sato H, Carvalho G, Sato T, Lattermann R,MatsukawaT, Schricker T. The association of preoperative glycemic control, intraoperative insulin sensitivity, and outcomesafter cardiac surgery. J Clin Endocrinol Metab 2010; 95: 4338-44
35. GustafssonUO, Thorell A,SoopM, LjungqvistO,NygrenJ.HaemoglobinA1c as a predictor of postoperative hyperglycaemia and complications aftermajor colorectal surgery. Br J Surg 2009; 96: 1358-64
36. Dronge AS, Perkal MF, Kancir S, Concato J, Aslan M, Rosenthal RA. Long-term glycemic control and postoperative infectious complications. Arch Surg 2006; 141: 375-80; discussion37
37. Hudson CC,Welsby IJ, Phillips-Bute B, et al. Glycosylated hemoglobin levels and outcome in non-diabetic cardiac surgery patients. Can J Anaesth 2010; 57: 565-72
38. Han HS, Kang SB. Relations between long-term glycemic control and postoperative wound and infectious complications after total knee arthroplasty in type2 diabetics. Clin Orthoped Surg 2013; 5: 118-23
39. Dluhy RG, McMahon GT. Intensive glycemic control in the ACCORD and ADVANCE trials. N Engl J Med 2008; 358: 2630-3
40. Little RR, Rohlfing CL. The long and winding road to optimal HbA1c measurement. Clin Chim Acta 2013; 418: 63-71
41. Mraovic B, Suh D, Jacovides C, Parvizi J. Perioperative hyperglycemia and postoperative infection after lower limb arthroplasty. J Diab Sci Technol 2011; 5: 412-8
42. TrickWE,SchecklerWE,Tokars JI, et al. Modifiablerisk factors associated with deep sternal site infection after coronaryartery bypass grafting. J Thorac Cardiovasc Surg 2000; 119: 108-14
43. Mraovic B, Hipszer BR,Epstein RH,Pequignot EC,Parvizi J, JosephJI. Preadmission hyperglycemia is an independent risk factor for in-hospital symptomatic pulmonary embolism after major orthopedic surgery. J Arthroplasty 2010; 25: 64-70
44. McGirt MJ, Woodworth GF, Brooke BS, et al. Hyperglycemia independently increasesthe risk of perioperative stroke,myocardial infarction, and death after carotid endarterectomy. Neurosurgery 2006; 58: 1066-73; discussion 1066-73
45. Hatzakorzian R, Bui H, Carvalho G, Shan WL, Sidhu S, Schricker T. Fasting blood glucose levels in patients presenting for elective surgery. Nutrition 2011; 27: 298-301
46. Puskas F, Grocott HP, White WD, Mathew JP, Newman MF, Bar-Yosef S. Intraoperative hyperglycemia and cognitive decline after CABG. Ann Thorac Surg 2007; 84: 1467-73
47. Krinsley JS. Blood glucose control in critically ill patients: the impact of diabetes. Crit Care Med 2009; 37: 382; author reply 382-3
48. Smith FG, Sheehy AM, Vincent JL, Coursin DB. Critical illness-induced dysglycaemia: diabetes and beyond. Crit Care 2010; 14: 327
49. Clement S, Braithwaite SS, Magee MF, et al. Management of diabetes and hyperglycemia in hospitals. Diabetes Care 2004; 27: 553-91
50. Bochicchio GV, Sung J, Joshi M, et al. Persistent hyperglycemia is predictive of outcome in critically ill trauma patients. J Trauma 2005; 58: 921-4
51. Bochicchio GV, Salzano L, Joshi M, Bochicchio K, Scalea TM. Admission preoperative glucose is predictive of morbidity and mortality in traumapatientswhorequire immediate operative intervention. Am Surg 2005; 71: 171-4
52. Kerby JD, Griffin RL, MacLennan P, Rue LW. Stress-induced hyperglycemia, not diabetic hyperglycemia, is associated with higher mortality in trauma. Ann Surg 2012; 256: 446-52
53. Karunakar MA, Staples KS. Does stress-induced hyperglycemia increase the risk of perioperative infectious complications in orthopaedic trauma patients? J Orthopaed Trauma 2010; 24: 752-6
54. Egi M, Bellomo R, Stachowski E, French CJ, Hart G. Variability of blood glucose concentration and short-term mortality in critically ill patients. Anesthesiology 2006; 105: 244-52
55. Krinsley JS. Glycemic variability: a strong independent predictor of mortality in critically ill patients. Crit Care Med 2008; 36: 3008-13
56. Hermanides J, Vriesendorp TM, Bosman RJ, Zandstra DF, Hoekstra JB, Devries JH. Glucose variability is associated with intensive care unit mortality. Crit Care Med 2010; 38: 838-42
57. Inzucchi SE. Glycemic management of diabetes in the perioperative setting. Int Anesthesiol Clin 2002; 40: 77-93
58. Joshi GP, Chung F, Vann MA, et al. Society for Ambulatory Anesthesia consensus statementon perioperative blood glucosemanagement in diabetic patients undergoing ambulatory surgery. Anesth Analg 2010; 111: 1378-87
59. Cryer PE, Axelrod L, Grossman AB, et al. Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2009; 94: 709-28
60. Shorr RI, Ray WA, Daugherty JR, Griffin MR. Incidence and risk factors for serious hypoglycemia in older persons using insulin or sulfonylureas. Arch Intern Med 1997; 157: 1681-6
61. Mooradian AD, BernbaumM, Albert SG. Narrative review: a rational approach to starting insulin therapy. Ann Intern Med 2006; 145: 125-34
62. De Hert S, Imberger G, Carlisle J, et al. Preoperative evaluation of the adult patient undergoing non-cardiac surgery: guidelines from the European Society of Anaesthesiology. Eur J Anaesthesiol 2011; 28: 684-722
63. Kohl BA,HammondMS, Ochroch EA. Implementation of an intraoperative glycemic control protocol for cardiac surgery in a high-acuity academic medical center: an observational study. J Clin Anesth 2013; 25: 121-8
64. Gandhi GY, Nuttall GA, Abel MD, et al. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery: a randomized trial. Ann Intern Med 2007; 146: 233-43
65. Doenst T,Wijeysundera D, Karkouti K, et al. Hyperglycemia during cardiopulmonary bypass is an independent risk factor for mortality in patients undergoing cardiac surgery. J Thorac Cardiovasc Surg 2005; 130: 1144
66. Ouattara A, Lecomte P, Le Manach Y, et al. Poor intraoperative blood glucose control is associated with a worsened hospital outcomeafter cardiac surgery in diabetic patients. Anesthesiology 2005; 103: 687-94
67. Gandhi GY, Nuttall GA, Abel MD, et al. Intraoperative hyperglycemia and perioperative outcomes in cardiac surgery patients. Mayo Clin Proc 2005; 80: 862-6
68. Maerz LL, Akhtar S. Perioperative glycemic management in 2011: paradigm shifts. Curr Opin Crit Care 2011; 17: 370-5
69. Girard M, Schricker T. Perioperative glucose control: living in uncertain times-continuing professional development. Can J Anaesth 2011; 58: 312-29
70. van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med 2001; 345: 1359-67
71. Bellomo R, Egi M. Glycemic control in the intensive care unit: why we should wait for NICE-SUGAR. Mayo Clin Proc 2005; 80: 1546-8
72. Krinsley J. Glycemic control in critically ill patients: Leuven and beyond. Chest 2007; 132: 1-2
73. Van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. N Engl J Med 2006; 354: 449-61
74. Van den Berghe G, Wilmer A, Milants I, et al. Intensive insulin therapy in mixed medical/surgical intensive care units: benefit versus harm. Diabetes 2006; 55: 3151-9
75. Finfer S, Heritier S, Committee NSM, Committee SSE. The NICESUGAR (Normoglycaemia in Intensive Care Evaluation and Survival Using Glucose Algorithm Regulation) Study: statistical analysis plan. Crit Care Resusc 2009; 11: 46-57
76. Preiser JC. Restoring normoglycaemia: not so harmless. Crit Care 2008; 12: 116
77. Preiser JC, Devos P. Clinical experience with tight glucose control by intensive insulin therapy. Crit Care Med 2007; 35: S503-7
78. Hua J, Chen G, Li H, et al. Intensive intraoperative insulin therapy versus conventional insulin therapy during cardiac surgery: a meta-analysis. J Cardiothorac Vasc Anesth 2012; 26: 829-34
79. Moghissi ES, Korytkowski MT, DiNardo M, et al. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Endocr Pract 2009; 15: 353-69
80. Qaseem A, Humphrey LL, Chou R, Snow V, Shekelle P, Clinical Guidelines Committee of the American College of Physicians. Use of intensive insulin therapy for the management of glycemic control in hospitalized patients: a clinical practice guideline from the American College of Physicians. Ann Intern Med 2011; 154: 260-7
81. Poldermans D, Bax JJ, Boersma E, et al. Guidelines for preoperative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery: the Task Force for Preoperative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-cardiac Surgery of the European Society of Cardiology (ESC) and endorsed by the European Society of Anaesthesiology (ESA). Eur J Anaesthesiol 2010; 27: 92-137
82. Umpierrez GE, Latif K, Stoever J, et al. Efficacy of subcutaneous insulin lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis. Am J Med 2004; 117: 291-6
83. Federico F. Preventingharmfromhigh-alertmedications. Jt Comm J Qual Patient Saf 2007; 33: 537-42
84. Rice MJ, Pitkin AD, Coursin DB. Review article: glucose measurement in the operating room: more complicated than it seems. Anesth Analg 2010; 110: 1056-65
85. Sacks DB, Bruns DE, Goldstein DE, Maclaren NK, McDonald JM, Parrott M. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem 2002; 48: 436-72
86. Gan TJ, Meyer TA, Apfel CC, et al. Society for Ambulatory Anesthesia guidelines for the management of postoperative nausea and vomiting. Anesth Analg 2007; 105: 1615-28, table of contents
87. Practice guidelines for postanesthetic care: a report by the American Society of Anesthesiologists Task Force on Postanesthetic Care. Anesthesiology 2002; 96: 742-52
88. Dellinger RP, Carlet JM, Masur H, et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Intensive Care Med 2004; 30: 536-55
89. Dellinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008; 36: 296-327
90. American Diabetes Association. Standards of medical care in diabetes- 2008. Diabetes Care 2008; 31 (Suppl. 1): S12-54
91. Rodbard HW, Blonde L, Braithwaite SS, et al. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus. Endocr Pract 2007; 13 (Suppl. 1): 1-68
92. Brunkhorst FM, Engel C, Bloos F, et al. Intensive insulin therapyand pentastarch resuscitation in severe sepsis.NEngl JMed2008; 358: 125-39
93. Arabi YM, Dabbagh OC, Tamim HM, et al. Intensive versus conventional insulin therapy:arandomizedcontrolled trial in medicaland surgical critically ill patients. Crit Care Med 2008; 36: 3190-7
94. Preiser JC, Devos P, Ruiz-Santana S, et al. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Med 2009; 35: 1738-48
95. De La Rosa Gdel C, Donado JH, Restrepo AH, et al. Strict glycaemic control in patients hospitalised in a mixed medical and surgical intensive care unit: a randomised clinical trial. Crit Care 2008; 12: R120
96. NICE-SUGARStudy Investigators, Finfer S, Chittock DR, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009; 360: 1283-97
97. Lazar HL, Chipkin SR, Fitzgerald CA, Bao Y, Cabral H, Apstein CS. Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation 2004; 109: 1497-502
98. LathamR, Lancaster AD, Covington JF, Pirolo JS, Thomas CS Jr. The association of diabetes and glucose control with surgical-site infections among cardiothoracic surgery patients. Infect Control Hosp Epidemiol 2001; 22: 607-12
99. Krinsley JS. Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin Proc 2004; 79: 992-1000
100. Wiener RS, Wiener DC, Larson RJ. Benefits and risks of tight glucose control in critically ill adults: a meta-analysis. J Am Med Assoc 2008; 300: 933-44
101. Ishihara M, Kojima S, Sakamoto T, et al. Acute hyperglycemia is associated with adverse outcome after acute myocardial infarction in the coronary intervention era. Am Heart J 2005; 150: 814-20
102. Finney SJ, Zekveld C, Elia A, EvansTW. Glucose control and mortality in critically ill patients. J Am Med Assoc 2003; 290: 2041-7
103. Dellinger RP, Levy MM, Rhodes A, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med 2013; 39: 165-228
104. Ichai C, Preiser JC. International recommendations for glucose control in adult non diabetic critically ill patients. Crit Care 2010; 14: R166
105. Jacobi J, Bircher N, Krinsley J, et al. Guidelines for the use of an insulin infusion for themanagement of hyperglycemia in critically ill patients. Crit Care Med 2012; 40: 3251-76
106. Societe Francaise d'Anesthesie et de Reanimation. Formal recommendations by the experts. Glycemic control in intensive care unit and during anaesthesia. Ann Fr Anesth Reanim 2009; 28: 410-5
107. Scalea TM, Bochicchio GV, Bochicchio KM, Johnson SB, Joshi M, Pyle A. Tight glycemic control in critically injured trauma patients. Ann Surg 2007; 246: 605-10; discussion 10-2
108. Collier B, Diaz J Jr, Forbes R, et al. The impact of a normoglycemic management protocol on clinical outcomes in the trauma intensive care unit. J Parenter Enteral Nutr 2005; 29: 353-8; discussion 359
109. Helbok R, Schmidt JM, Kurtz P, et al. Systemic glucose and brain energy metabolism after subarachnoid hemorrhage. Neurocrit Care 2010; 12: 317-23
110. Ryden L, Standl E, Bartnik M, et al. Guidelines on diabetes, prediabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J 2007; 28: 88-136
111. HandelsmanY,MechanickJI, BlondeL, et al.AmericanAssociation of Clinical Endocrinologists medical guidelines for clinical practice for developing a diabetes mellitus comprehensive care plan. Endocr Pract 2011; 17 (Suppl. 2): 1-53
112. Fasching P, Huber J, Clodi M, Abrahamian H, Ludvik B. Position statement: surgery and diabetes mellitus. Wien Klin Wochenschr 2012; 124 (Suppl. 2): 115-9
113. Krinsley JS. Glycemic control, diabetic status, and mortality in a heterogeneous population of critically ill patients before and during the era of intensive glycemic management: six and one-half years experience at a university-affiliated community hospital. Semin Thorac Cardiovasc Surg 2006; 18: 317-25
114. Vriesendorp TM, van Santen S, DeVries JH, et al. Predisposing factors for hypoglycemia in the intensive care unit. Crit Care Med 2006; 34: 96-101
115. O'Malley CW, Emanuele M, Halasyamani L, Amin AN. Bridge over troubled waters: safe and effective transitions of the inpatient with hyperglycemia. J Hosp Med 2008; 3: 55-65
116. FurnaryAP, Braithwaite SS. Effects of outcome on in-hospital transition from intravenous insulin infusion to subcutaneous therapy. Am J Cardiol 2006; 98: 557-64
117. Donaldson S, Villanuueva G, Rondinelli L, Baldwin D. Rush University guidelines and protocols for the management of hyperglycemia in hospitalized patients: elimination of the sliding scale and improvement of glycemic control throughout the hospital. Diabetes Educ 2006; 32: 954-62
118. Ramos P, Childers D, Maynard G, et al. Maintaining glycemic control when transitioning from infusion insulin: a protocoldriven, multidisciplinary approach. J Hosp Med 2010; 5: 446-51
119. Magaji V, Johnston J. Inpatient management of hyperglycemia and diabetes. Clin Diab 2011; 29: 3-9
120. Avanzini F, Marelli G, DonzelliW, et al. Transition from intravenous to subcutaneous insulin: effectiveness and safety of a standardized protocol and predictors of outcome in patients with acute coronary syndrome. Diabetes Care 2011; 34: 1445-50
121. Weant KA, Ladha A. Conversion from continuous insulin infusions to subcutaneous insulin in critically ill patients. Ann Pharmacother 2009; 43: 629-34
122. Umpierrez GE,Smiley D, Hermayer K, et al. Randomized study comparingabasal-bolus withabasalplus correctioninsulin regimenfor the hospital management of medical and surgical patients with type2 diabetes: basal plus trial. Diabetes Care 2013; 36: 2169-74
123. Umpierrez GE, Hellman R, Korytkowski MT, et al. Management of hyperglycemia in hospitalized patients in non-critical care setting: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2012; 97: 16-38
124. Hoogwerf BJ. Perioperative management of diabetes mellitus: how should we act on the limited evidence? Cleve Clin J Med 2006; 73 (Suppl. 1): S95-9
125. Rice MJ, Coursin DB. Continuous measurement of glucose: facts and challenges. Anesthesiology 2012; 116: 199-204
126. Slama G, Traynard PY, Desplanque N, et al. The search for an optimized treatment of hypoglycemia. Carbohydrates in tablets, solutin, or gel for the correction of insulin reactions. Arch Intern Med 1990; 150: 589-93
127. Ingels C, Debaveye Y, Milants I, et al. Strict blood glucose control with insulin during intensive care after cardiac surgery: impact on 4-years survival, dependency on medical care, and quality-of-life. Eur Heart J 2006; 27: 2716-24
128. Zerr KJ, Furnary AP, Grunkemeier GL, Bookin S, Kanhere V, Starr A. Glucose control lowers the risk of wound infection in diabetics after open heart operations. Ann Thorac Surg 1997; 63: 356-61
129. Furnary AP, Zerr KJ, Grunkemeier GL, Starr A. Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann Thorac Surg 1999; 67: 352-60; discussion 60-2
130. Leibowitz G, Raizman E, Brezis M, Glaser B, Raz I, Shapira O. Effects of moderate intensity glycemic control after cardiac surgery. Ann Thorac Surg 2010; 90: 1825-32
131. Coester A, Neumann CR, Schmidt MI. Intensive insulin therapy in severe traumatic brain injury: a randomized trial. J Trauma 2010; 68: 904-11
132. Jeremitsky E,OmertLA,DunhamCM, Wilberger J,Rodriguez A. The impact of hyperglycemia on patients with severe brain injury. J Trauma 2005; 58: 47-50
133. Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke 2001; 32: 2426-32
134. Bruno A, Levine SR, Frankel MR, et al. Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke Trial. Neurology 2002; 59: 669-74
135. Garg R, Chaudhuri A, Munschauer F, Dandona P. Hyperglycemia, insulin, and acute ischemic stroke: a mechanistic justification for a trial of insulin infusion therapy. Stroke 2006; 37: 267-73
136. Fogelholm R, Murros K, Rissanen A, Avikainen S. Admission blood glucose and short term survival in primary intracerebral haemorrhage: a population based study. J Neurol Neurosurg Psychiatry 2005; 76: 349-53
137. Kruyt ND, Biessels GJ, de Haan RJ, et al. Hyperglycemia and clinical outcome in aneurysmal subarachnoid hemorrhage: a metaanalysis. Stroke 2009; 40: e424-30
138. Bilotta F, Spinelli A, Giovannini F, Doronzio A, Delfini R, Rosa G. The effect of intensive insulin therapy on infection rate, vasospasm, neurologic outcome, and mortality in neurointensive care unit after intracranial aneurysm clipping in patients with acute subarachnoid hemorrhage: a randomized prospective pilot trial. J Neurosurg Anesthesiol 2007; 19: 156-60
139. Pasternak JJ, McGregor DG, Schroeder DR, et al. Hyperglycemia in patients undergoing cerebral aneurysm surgery: its association with long-term gross neurologic and neuropsychological function. Mayo Clin Proc 2008; 83: 406-17
140. Vaquerizo Alonso C, Grau Carmona T, Juan Diaz M. Guidelines for specialized nutritional and metabolic support in the critically-ill patient: update. Consensus SEMICYUC-SENPE: hyperglycemia and diabetes mellitus. Nutr Hosp 2011; 26 (Suppl. 2): 46-9
141. Magaji V, Nayak S, Donihi AC, et al. Comparison of insulin infusion protocols targeting 110-140 mg/dL in patients after cardiac surgery. Diabetes Technol Ther 2012; 14: 1013-7